Russia's Luna-25 spacecraft crashes into Moon
21-08-2023, 06:33

Font size: [ A+ ] / [ A- ]

Russia's unmanned Luna-25 spacecraft has crashed into the Moon after spinning out of control, officials say.

It was Russia's first Moon mission in almost 50 years.

The craft was due to be the first ever to land on the Moon's south pole, but failed after encountering problems as it moved into its pre-landing orbit.

It was set to explore a part of the Moon which scientists think could hold frozen water and precious elements.

Roscosmos, Russia's state space corporation, said on Sunday morning that it had lost contact with the Luna-25 shortly after 14:57pm (11:57 GMT) on Saturday.

Preliminary findings showed that the 800kg lander had "ceased to exist as a result of a collision with the surface of the Moon", it said in a statement.

It said a special commission would look into why the mission failed.

The loss of Luna-25 is a blow to Roscosmos. Russia's civilian space programme has been in decline for several years, as state funding is increasingly directed towards the military.

Russia was racing to the Moon's south pole against India, whose Chandrayaan-3 spacecraft is scheduled to land there in the coming days and send a rover to explore the rocks and craters, gathering data and images to send back to Earth.

Parts of the Moon's south pole remain permanently in shadow, which makes finding water a possibility.

A spokesperson for the Indian space agency Isro described the Luna-25 crash as "unfortunate".

"Every space mission is very risky and highly technical. It's unfortunate that Luna-25 has crashed," they told the BBC.

Roscosmos had acknowledged that the Luna-25 mission was risky and could fail. The craft launched from Vostochny Cosmodrome in the far eastern Amur region of Russia on 11 August, and then successfully entered the moon's orbit on Wednesday of this week.

It was expected to make history by making a soft landing on Monday or Tuesday, just days before the Indian touchdown.

No country has ever landed on the Moon's south pole before, although both the US and China have landed softly on the Moon's surface.

Luna-25 was Russia's first Moon mission since 1976, when it was part of the Soviet Union. That mission, Luna-24, landed successfully.

 

BBC

Comments: 2591
#1371   Leila
      
Look at my blog :: Shayne
6 October 2025 18:52
#1370   Mari
      
Here is my webpage :: highstakes 777
Online
6 October 2025 10:30
#1369   Celesta
      
Here is my blog; Pokertube
6 October 2025 06:31
#1368   Arnulfo
      
With havin so much content do you ever run into any
issues of plagorism or copyright infringement? My site has a lot of exclusive content I've either created myself or outsourced but it seems a lot of
it is popping it up all over the web without my agreement.
Do you know any solutions to help protect against content
from being stolen? I'd definitely appreciate it.

Here is my site ... Play Poker Online
6 October 2025 06:22
#1367   Katharina
      
Here is my web page ... Site poker
6 October 2025 01:52
#1366   Garrett
      
Peptides such as CJC‑1295 and ipamorelin are increasingly popular among bodybuilders, athletes,
and researchers seeking anabolic benefits. While they can enhance growth hormone secretion and potentially improve muscle mass, recovery,
and fat loss, their use is not without risk.
Understanding the side effect profile for each peptide—and how it may differ depending on dosage, administration route, and individual physiology—is essential for anyone considering incorporating these compounds into a supplementation or training regimen.



CJC 1295 Ipamorelin Side Effects: Research

Clinical investigations into CJC‑1295, a growth hormone releasing peptide (GHRP) that
stimulates the pituitary to release growth hormone over an extended period, have documented several adverse effects.
In controlled human trials, participants reported transient increases in blood glucose
levels, leading to mild hyperglycemia especially when combined with other anabolic agents.

Other common side effects include water retention, which can manifest
as bloating or a feeling of fullness, and mild headaches that typically resolve within 24 hours after stopping
the peptide. In some studies, users experienced increased hunger due to elevated growth hormone activity stimulating appetite pathways in the hypothalamus.
Although serious complications were rare,
a small number of subjects reported localized injection site reactions such as erythema, swelling, or discomfort at the subcutaneous administration point.




Ipamorelin, another GHRP known for its selective prolactin inhibition and minimal impact on cortisol levels, has also been studied in both animal models and human volunteers.
Research indicates that ipamorelin’s side effect profile is
comparatively mild. Reported adverse events include transient fatigue or drowsiness following injection, which
may be attributed to a temporary surge in growth hormone levels affecting circadian rhythms.

Mild flushing or tingling sensations at the injection site are also
documented but generally resolve within a few hours. Rarely, participants have reported a sensation of "buzz" or mild dizziness that is believed to stem from transient blood pressure changes.
Importantly, no long‑term endocrine disruptions
were observed in studies lasting up to 12 weeks.



When combining CJC‑1295 and ipamorelin, some users report synergistic side
effects such as pronounced water retention or increased appetite.
This combination can also lead to a more noticeable rise in insulin-like
growth factor 1 (IGF‑1) levels, which may elevate
the risk of unwanted cell proliferation if used chronically without medical supervision. As with any peptide therapy, it is advisable to monitor hormone panels regularly and consult healthcare professionals before initiating or
altering dosing regimens.



Item added to your cart

If you are considering adding CJC‑1295 or ipamorelin to
your supplementation list, ensure that the vendor provides clear dosage instructions and information on potential side effects.
It’s prudent to start with a lower dose, observe how your body responds, and keep detailed logs of any symptoms such as headaches, water retention,
changes in appetite, or injection site reactions.
Should you notice persistent or severe discomfort, discontinue
use and seek medical advice promptly. Maintaining an accurate record will help both you and any supervising clinician assess the safety and efficacy of these peptides over time.
6 October 2025 01:38
#1365   Florida
      
Here is my web blog; HighStakesDB
6 October 2025 01:09
#1364   Elliott
      
6 October 2025 00:45
#1363   Javier
      
5 October 2025 21:48
#1362   Monique
      
Look at my homepage - PokerTube
5 October 2025 18:37
#1361   Anderson
      
my blog Randall
5 October 2025 18:06
#1359   Candelaria
      
Take a look at my site - Highstakes Login
5 October 2025 13:21
#1358   Elyse
      
5 October 2025 13:19
#1357   Julienne
      
5 October 2025 11:43
#1356   Dorcas
      
how to buy testosterone

References:


ansgildied.com
5 October 2025 10:15
#1355   Benjamin
      
extreme anabolic

References:


https://mianswer.com/user/rakewave95
5 October 2025 09:09
#1354   Antonietta
      
I think this is one of the most important info for me. And i'm glad reading your article.
But wanna remark on some general things, The web site
style is perfect, the articles is really excellent
: D. Good job, cheers

Also visit my web-site :: Online Gaming
5 October 2025 08:01
#1353   Alta
      
Also visit my web blog ... High Stack poker
5 October 2025 04:40
#1352   Muoi
      
Feel free to visit my homepage - highstakespoker
5 October 2025 04:07
Add Comments

Name:*
E-Mail:
  Geo Keyboard  
 

Dear reader, guardian.ge welcomes your comments. Please express your views on topic and be respectful of others.

bold italic underline strike | align left centered align right | Ensert smilies insert linkInsert protected URL Choice the color | hidden text insert quote Convert selected text from transliteration to Cyrillic alphabet Insert spoiler

Code: *


Back1 ... 58 59 60 61 62 63 64 65 66 ... 130Next